BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19576173)

  • 1. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
    Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA
    Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
    Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in CCR2 antagonists.
    Xia M; Sui Z
    Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.
    Brodmerkel CM; Huber R; Covington M; Diamond S; Hall L; Collins R; Leffet L; Gallagher K; Feldman P; Collier P; Stow M; Gu X; Baribaud F; Shin N; Thomas B; Burn T; Hollis G; Yeleswaram S; Solomon K; Friedman S; Wang A; Xue CB; Newton RC; Scherle P; Vaddi K
    J Immunol; 2005 Oct; 175(8):5370-8. PubMed ID: 16210643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
    Zweemer AJ; Nederpelt I; Vrieling H; Hafith S; Doornbos ML; de Vries H; Abt J; Gross R; Stamos D; Saunders J; Smit MJ; Ijzerman AP; Heitman LH
    Mol Pharmacol; 2013 Oct; 84(4):551-61. PubMed ID: 23877010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
    Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
    BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
    Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
    Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.
    Wisniewski T; Bayne E; Flanagan J; Shao Q; Wnek R; Matheravidathu S; Fischer P; Forrest MJ; Peterson L; Song X; Yang L; Demartino JA; Struthers M
    J Immunol Methods; 2010 Jan; 352(1-2):101-10. PubMed ID: 19913021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series.
    Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Tsutsumi T; Sudo M; Endo N; Muroga Y; Hada T; Fanning D; Saunders J; Kato Y; Myers PL; Tarby CM
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1869-73. PubMed ID: 18313297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists.
    Herath KB; Jayasuriya H; Ondeyka JG; Polishook JD; Bills GF; Dombrowski AW; Cabello A; Vicario PP; Zweerink H; Guan Z; Singh SB
    J Antibiot (Tokyo); 2005 Nov; 58(11):686-94. PubMed ID: 16466022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats.
    Dansereau MA; Gosselin RD; Pohl M; Pommier B; Mechighel P; Mauborgne A; Rostene W; Kitabgi P; Beaudet N; Sarret P; Melik-Parsadaniantz S
    J Neurochem; 2008 Jul; 106(2):757-69. PubMed ID: 18419759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
    Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
    Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists.
    Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP
    J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-content analysis of CCR2 antagonists on human primary monocytes.
    Kredel S; Wolff M; Hobbie S; Bieler M; Gierschik P; Heilker R
    J Biomol Screen; 2011 Aug; 16(7):683-93. PubMed ID: 21540351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes.
    Kuscher K; Danelon G; Paoletti S; Stefano L; Schiraldi M; Petkovic V; Locati M; Gerber BO; Uguccioni M
    Eur J Immunol; 2009 Apr; 39(4):1118-28. PubMed ID: 19291700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol reduces MCP-1-induced chemotaxis and adhesion of THP-1 monocytes by inhibiting CCR2 gene expression.
    Chuang SY; Yang SH; Pang JH
    Biochem Biophys Res Commun; 2011 Jul; 411(2):402-8. PubMed ID: 21756880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists.
    Lim JW; Oh Y; Kim JH; Oak MH; Na Y; Lee JO; Lee SW; Cho H; Park WK; Choi G; Kang J
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2099-102. PubMed ID: 20223662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium receptor stimulates chemotaxis and secretion of MCP-1 in GnRH neurons in vitro: potential impact on reduced GnRH neuron population in CaR-null mice.
    Chattopadhyay N; Jeong KH; Yano S; Huang S; Pang JL; Ren X; Terwilliger E; Kaiser UB; Vassilev PM; Pollak MR; Brown EM
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E523-32. PubMed ID: 17003237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.